It is important that clinicians and laboratorians, including clinical chemists and pathologists, recognize and understand the clinical significance of abnormal liver function tests. The liver regulates many important metabolic f u n c t i o n s . Hepatic injury is associated with distortion of these metabolic functions. Hepatic disease can be evaluated and diag.nosed by determining serum concentrations of a number of serum analytes. Many serum analytes exist to assist in the biochemical diagnosis of liver disease. The focus of this paper is on the analytes which are associated with hepatic necrosis, cholestasis, defects in excretion and end stage hepatic disease which results in decreased synthetic function. The abnormalities of these serum analytes will be correlated with the important types of liver disease.
INTRODUCTION
The liver regulates many important metabolic functions (Table 1) . Diffuse severe hepatic injury is associated with marked distortion of these metabolic functions and can be evaluated by determining serum concentrations of a relatively small number of analytes (Table 2 ).
In general, only four serum biochemical tests are n e c e s s a r y to assess hepatic abnormalities (1) . These analytes are (1) alanine a m i n o t r a n s f e r a s e (ALT) (EC 2.6.1.2) and aspartate aminotransferase (AST), (EC 2.6.1.1), (2) alkaline phosphatase (ALP) (EC 3.1.3.1), prealbumin or prothrombin to measure hepatic synthetic function (Table 3) .
Author for correspondence : Dr. Paul L. Wolf, M.D. at above address The aminotransferases are elevated with acute hepatic cell injury, in contrast to ALP, which is elevated with cholestasis~. Serum bilirubin is important in assessing the abd~ty (2) .
The pattern of results from the above four tests allows classification of liver disease into the broad categories of (1) acute hepatitis, (2) chronic hepatitis, (3) cirrhosis, (4) cholestasis, and (5) neoplasms, (Table 4 ). In conjunction with orther clinical parameters, the pattern of liver function test results is useful in classfying the type of liver disease present, following the course of hepatic disease, and predicting prognosis.
Each of the four analytes will be correlated to classify each type of liver disease. A diagnostic pattern of abnormalities in these four analytes ~s extremely useful to establish the diagnostic pattern of abnormalities in these four analytes is extremely useful to establish the diagnosis in patients afflictfed with hepatic disease (3,4).
II. BASIC LIVER FUNCTION TESTS TO IDENTIFY ABNORMALITIES IN HEPATIC

SYNTHESIS
Albumin
Albumin is synthesized in the liver. Its half life is approximately twenty days The rate of synthesis is variable depending on nutritional status and age. Albumin is not stored in the liver. Decreased serum albumin is caused by many diseases. Hypoalbuminemia is frequently found in end stage liver disease (Table 5 ).
Cirrhosis due to many diseases is associated with diminished numbers of hepatocytes and thus decreased hepatic capacity to synthesize albumin (5) . Impaired synthesis also occurs due Severe generahzed dermatitis or severe burns will also result in depletion of serum albumin due to denudat=on of skin. Catabolism of albumin is increased in hyperthyroidism and diseases associated with excessive production or utilization of cort=sol. Immunochemical methods such as nephelometry are highly specific and more sensitive. Albumin assay by an immunochemical method does not pose the same problem as ~mmunochemical methods for other specific proteins. Reliable, consistent antisera can be generated because highly purified protein is available, and the pure protein can also be used (7).
Ill. TESTS OF SUBSTANCES METABOLIZED AND EXCRETED BY THE LIVER
Bilirubin is an orange-yellow pigment produced from protoporphyrln. Biliverdm Js a green pigment. The total daily bil~rubin production is approximately 300 mg and ~s derived from the heme moiety of hemoglobin. 
IV. ETIOLOGY OF INCREASED UNCONJUGATED BILIRUBIN
The major cause of increased serum unconjugated bilirubin is hemolytic anemia (Table   7) . Hemolysis results in increased serum unconjugated bilirubin in the absence of liver disease. The hemolysis of sickle cell disease can (Table 9 ). ALT and AST are present in liver, heart, skeletal muscle, kidney, in high activity with lesser amounts in many other organs (Table 10) .
AST is a dimer of two identical subunits. The molecular mass of the holoenzyme from human liver is 93,000 daltons. M-AST is also a dimer with a molecular mass of 90,400 daltons (Table   11 ). 
VIII LIVER FUNCTION ENZYME TESTS DEMONSTRATING CHOLESTASIS
Enzymes released from biliary and hepatocyte plasma membranes, canalicular membrane, endothelium of hepatic veins or enzymes synthesized at an increased rate in cholestas~s. (Table 13 ).
ALKALINE PHOSPHATASE(ALP)
When the serum ALP is significantly decreased below the lower limit of the reference range, the differential diagnoses include (1) congenital hypophosphatasemia (the converse of familial hyperphosphatasemia), in which infants and chaldren are severely affected by arrested bone growth and have a propensity for fracture of multiple bones, (2) zinc deficiency; (3) magnesium deficiency; (4) hypothyroidism; and (5) vitamin B~2 deficiency (Table 14 ) (23, 24) .
The condition familial hyperphosphatasemia of childhood is associated with an elevated serum ALP in healthy children who do not have hepatic or bone diease. They have a genetic familial propensity for excessive tissue production of ALP. found in a patient with bronchogenic carcinoma;
it is an isoenzyme that has proven to be chemically and functionally similar to placental ALP (32,33). One difference is the greater placental form thus suggesting differences in their tertiary structure.
Two other cancer associated ALP isoenzymes are the Nagao and Kasahara forms.
The Nagao isoenzyme was found in a patient with pleural carcinoma; it resembled the Regan isoenzyme in its heat stablity, electrophoretic migration, and precipitation with antiplacental ALP antibody. It differed from the Regan form by being more sensitive to inhibition by Lphenylalanine or leucine. The Kasahara ALP, first found in a patient with hepatoma, migrated (Table 18 ). In the future, specific monoclonal antibodies to these isoforms may be useful to clinically evaluate these serum ALP isoforms, without the use of electrophoresis. (Table 19) . 
Xll OTHER LIVER FUNCTION ANALYTES Ammonia
Plasma ammonia is useful for diagnosis, screening and follow up of patients with hepatic encephalopthy (Table 20) (55, 56) . The most common cause for an increase in plasma ammonia is end-stage liver disease, resulting in a defective hepatic urea cycle and inability of the liver to transform ammonia to urea. Plasma ammonia is derived from several sources.
Although some ammonia is derived from skeletal muscle metabolism, most of the ammonia is produced from bacterial metabolic action on protein in the intestine. The ammonia is transported to the liver via the portal vein where it is converted to urea. 
XXII HEPATITIS
Viral, alcoholic, drug, chemical, anoxic necrosis, congestive heart failure or shock.
Viral Hepatitis
In acute hepatitis, serum ALT is greater than AST with both frequently exceeding 1000 IU/ L. (Table 22) 
